repository
BROWSE
Cited 0 times in 
P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kang, J | - |
| dc.contributor.author | Lee, KH | - |
| dc.contributor.author | Kim, D | - |
| dc.contributor.author | Kim, S | - |
| dc.contributor.author | Kim, HR | - |
| dc.contributor.author | Kim, J | - |
| dc.contributor.author | Choi, JH | - |
| dc.contributor.author | An, HJ | - |
| dc.contributor.author | Kim, J | - |
| dc.contributor.author | Jang, JS | - |
| dc.contributor.author | Kim, B | - |
| dc.contributor.author | Kim, HT | - |
| dc.date.accessioned | 2019-12-10T06:53:47Z | - |
| dc.date.available | 2019-12-10T06:53:47Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.issn | 1556-0864 | - |
| dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/17817 | - |
| dc.format | application/pdf | - |
| dc.language.iso | en | - |
| dc.title | P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | 최, 진혁 | - |
| dc.type.local | Journal Papers | - |
| dc.identifier.doi | 10.1016/j.jtho.2018.08.1377 | - |
| dc.citation.title | Journal of thoracic oncology | - |
| dc.citation.volume | 13 | - |
| dc.citation.number | 10S | - |
| dc.citation.date | 2018 | - |
| dc.citation.startPage | S790 | - |
| dc.citation.endPage | S791 | - |
| dc.identifier.bibliographicCitation | Journal of thoracic oncology, 13(10S). : S790-S791, 2018 | - |
| dc.embargo.liftdate | 9999-12-31 | - |
| dc.embargo.terms | 9999-12-31 | - |
| dc.identifier.eissn | 1556-1380 | - |
| dc.relation.journalid | J015560864 | - |
- Appears in Collections:
- Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
